As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural ...
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.
The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...
Hosted on MSN15h
Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under TrumpShares of Moderna Inc. rose over 5% on Tuesday morning, reaching levels last seen more than a week ago, following news of a ...
Yesterday the World Health Organization (WHO) said Tanzania has 1 confirmed case of Marburg and 25 suspected cases all from ...
Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.
HealthDay on MSN10h
Moderna Receives $590M From HHS To Develop Bird Flu VaccineTUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback